they've just sold 59% of the only good thing they hadwonder what that'll do to the spthe way I read it it will also be months away from a commercial productimo the sp is gonna get a bit of a thumping
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
